MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.330
+0.020
+1.53%
After Hours: 1.339 +0.009 +0.70% 19:30 08/21 EDT
OPEN
1.330
PREV CLOSE
1.310
HIGH
1.390
LOW
1.310
VOLUME
250.26K
TURNOVER
--
52 WEEK HIGH
2.230
52 WEEK LOW
0.8500
MARKET CAP
33.91M
P/E (TTM)
-3.0365
1D
5D
1M
3M
1Y
5Y
1D
NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’
TipRanks · 4d ago
NanoViricides Announces Expects Its Phase II Clinical Trial Of NV-387 Oral Gummies To Treat Bundibugyo Ebolavirus And Other Ebola Viruses To Begin Soon In The Democratic Republic Of Congo
Benzinga · 4d ago
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
Barchart · 5d ago
Weekly Report: what happened at NNVC last week (0810-0814)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), BridgeBio Pharma (BBIO) and NanoViricides (NNVC)
TipRanks · 08/11 13:31
NanoViricides receives regulatory approval for Phase II trial of NV-387
TipRanks · 08/10 12:35
NanoViricides Wins DRC Approval To Begin Phase II Trial Of NV-387 Oral Gummies For Ebola
Benzinga · 08/10 12:34
Weekly Report: what happened at NNVC last week (0803-0807)?
Weekly Report · 08/10 10:27
More
About NNVC
NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.

Webull offers NanoViricides, Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.